Douglas J. Swartz
- Oncology top 10%
- Drug Transport and Resistance Mechanisms 8
-
- HIV/AIDS drug development and treatment 2
-
- DNA and Nucleic Acid Chemistry 2
- Protein Structure and Dynamics 1
-
- Nanoparticle-Based Drug Delivery 2
-
- Antibiotics Pharmacokinetics and Efficacy 2
-
- Blood properties and coagulation 1
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 1
- Co-authors
- Ina L. UrbatschGeoffrey ChangAndrew B. WardAnukriti SinghPaul SzewczykLorena MartinezEls PardonCédric Govaerts
- Journals
- Biochimica et Biophysica Acta (BBA) - Biomembranes (2 papers)Asian Journal of Andrology (1 paper)Scientific Reports (1 paper)
- Partner nations
- United StatesAustriaItaly
In The Last Decade
Douglas J. Swartz
10 papers receiving 423 citations
Peers
Comparison fields: 5 of 72
- Oncology 290
- Molecular Medicine 21
- Nutrition and Dietetics 62
- Infectious Diseases 67
- Molecular Biology 234
Countries citing papers authored by Douglas J. Swartz
This map shows the geographic impact of Douglas J. Swartz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas J. Swartz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas J. Swartz more than expected).
Fields of papers citing papers by Douglas J. Swartz
This network shows the impact of papers produced by Douglas J. Swartz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas J. Swartz. The network helps show where Douglas J. Swartz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Douglas J. Swartz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 10 | |
| 2 | 2020 | 2 | |
| 3 | 2017 | 55 | |
| 4 | 2016 | 15 | |
| 5 | 2016 | 1 | |
| 6 | 2014 | 11 | |
| 7 | 2013 | 207 | |
| 8 | 2012 | 16 | |
| 9 | 2011 | 83 | |
| 10 | 2007 | 26 | |
| 11 | Discourse and Direction: A Priest to the Temple, or, the Country Parson and the Elaboration of Sovereign Rule | 1994 | 2 |
About Douglas J. Swartz
Douglas J. Swartz is a scholar working on Oncology, Molecular Medicine and Biomaterials, having authored 11 papers that have together received 428 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (8 papers), Nanoparticle-Based Drug Delivery (2 papers), DNA and Nucleic Acid Chemistry (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), HIV/AIDS drug development and treatment (2 papers), Blood properties and coagulation (1 paper), Protein Structure and Dynamics (1 paper) and Cholangiocarcinoma and Gallbladder Cancer Studies (1 paper). The work is most often cited by research in Oncology (290 citations), Molecular Medicine (21 citations) and Nutrition and Dietetics (62 citations). Douglas J. Swartz has collaborated with scholars based in United States, Austria and Italy. Frequent co-authors include Ina L. Urbatsch, Geoffrey Chang, Andrew B. Ward, Anukriti Singh, Paul Szewczyk, Lorena Martinez, Els Pardon, Cédric Govaerts, Rupak Doshi and Pierre Falson. Their work appears in journals such as Biochimica et Biophysica Acta (BBA) - Biomembranes, Asian Journal of Andrology, Scientific Reports, Bioscience Reports and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.